Weaver C. Barksdale & Associates’s Eastman Chemical EMN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$908K Buy
11,897
+659
+6% +$47.5K 0.87% 59
2025
Q4
$718K Sell
11,238
-1,442
-11% -$88.9K 0.75% 59
2025
Q3
$799K Sell
12,680
-811
-6% -$56.6K 0.77% 58
2025
Q2
$1.01M Sell
13,491
-129
-0.9% -$10.1K 0.97% 56
2025
Q1
$1.2M Sell
13,620
-328
-2% -$31K 1.15% 51
2024
Q4
$1.27M Sell
13,948
-345
-2% -$35.4K 1.22% 48
2024
Q3
$1.6M Sell
14,293
-540
-4% -$54K 1.44% 42
2024
Q2
$1.45M Sell
14,833
-227
-2% -$22.5K 1.38% 46
2024
Q1
$1.51M Sell
15,060
-122
-0.8% -$10.7K 1.38% 44
2023
Q4
$1.36M Sell
15,182
-3,887
-20% -$310K 1.33% 44
2023
Q3
$1.46M Buy
19,069
+3,010
+19% +$250K 1.25% 48
2023
Q2
$1.34M Sell
16,059
-981
-6% -$79.8K 1.33% 49
2023
Q1
$1.44M Sell
17,040
-817
-5% -$70.2K 1.34% 50
2022
Q4
$1.45M Buy
17,857
+455
+3% +$36.7K 1.28% 52
2022
Q3
$1.24M Sell
17,402
-625
-3% -$56.2K 1.24% 55
2022
Q2
$1.62M Buy
18,027
+1,072
+6% +$111K 1.51% 44
2022
Q1
$1.9M Buy
16,955
+226
+1% +$26.5K 1.69% 27
2021
Q4
$2.02M Buy
+16,729
New +$1.86M 1.83% 23

Other funds holding EMN

Weaver C. Barksdale & Associates's EMN Position: Q1 2026 in Review

Weaver C. Barksdale & Associates increased its Eastman Chemical (EMN) stake by 5.9% in Q1 2026, buying an estimated $47.5K and bringing the position to 11,897 shares worth $908K. The position accounts for 0.87% of the portfolio, ranked #59.

Weaver C. Barksdale & Associates first reported a position in EMN in Q4 2021 and has held it in 18 quarters since. The position peaked at $2.02M in Q4 2021. 634 funds tracked by Wall St. Rank hold EMN as of Q1 2026.

  • Weaver C. Barksdale & Associates held 11,897 shares of Eastman Chemical worth $908K as of Q1 2026.
  • Weaver C. Barksdale & Associates bought 659 Eastman Chemical shares in Q1 2026, an estimated $47.5K.
  • Eastman Chemical made up 0.87% of Weaver C. Barksdale & Associates's portfolio in Q1 2026, its #59 holding.
  • Weaver C. Barksdale & Associates first reported a position in Eastman Chemical in Q4 2021 and has held it in 18 quarters since.
  • Weaver C. Barksdale & Associates's Eastman Chemical position peaked at $2.02M in Q4 2021.
  • 634 funds tracked by Wall St. Rank held Eastman Chemical as of Q1 2026.

Based on Weaver C. Barksdale & Associates's 13F filing for Q1 2026, filed 14 May 2026.